
|Videos|November 13, 2015
Stopping Memantine or Cholinesterase in Dementia Patients
Kalin M. Clifford, PharmD, BCPS, discusses when treatment with memantine or cholinesterase should be stopped in patients with dementia.
Advertisement
Kalin M. Clifford, PharmD, BCPS, discusses when treatment with memantine or cholinesterase should be stopped in patients with dementia.
This video was recorded at ASCP's Annual Meeting and Exhibition in Las Vegas, Nevada in October 2015.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Key Data, Interviews at the 2025 ASH Annual Meeting and Exposition
2
Guiding Patients With Sickle Cell Disease Through the Transformative Era of Gene Therapy
3
New Data Highlights Pharmacists’ Expanding Roles in Hematologic Malignancies
4
Bridging Response Emerges as Key Predictor of Cilta-Cel Outcomes in CARTITUDE-4
5

















































































































































































































